5 Underinvested Areas in Sleep Health That Healthtech Startups Are Finally Addressing
Most Americans suffer poor sleep, yet mainstream products remain limited to melatonin gummies, foam mattresses and CPAP machines. Healthtech startups are now targeting five under‑invested segments—perimenopausal hormonal sleep, shift‑worker circadian care, grounding and nervous‑system regulation, pediatric sleep beyond apnea, and at‑home sleep‑apnea testing. Companies such as Midi Health, Timeshifter, Earthbound Grounding, Huckleberry and Wesper are launching protocols, software and FDA‑cleared devices that directly address these gaps. The shift promises new revenue streams and broader clinical impact across previously ignored populations.
Novo's Pill for Kids; Altimmune’s $225M Offering; Merck Teams with Google Cloud
Novo Nordisk reported that its oral GLP‑1 drug Rybelsus reduced hemoglobin A1C by 0.83% in adolescents aged 10‑17 with type‑2 diabetes after about six months of treatment. The result marks the first pediatric efficacy data for a GLP‑1 pill, expanding...
Modern Healthcare Is Data‑rich but Insight‑poor
Healthcare now produces unprecedented volumes of real‑world data from EHRs, devices, claims and registries, yet this abundance has not yielded better patient outcomes. The author argues the gap stems from evidence that remains fragmented, retrospective and geared toward compliance rather...
Even Light Drinking Combined with Aging Is Linked to Reduced Brain Blood Flow and Thinner Tissue
A Stanford‑led study published in *Alcohol* found that even low‑level alcohol consumption, when combined with aging, is associated with reduced cerebral blood flow and thinner cortical tissue. Researchers examined 45 healthy adults (22‑70 years) and measured lifetime drinking patterns, brain...
Amneal to Buy a Biosimilar Company; Samsung Bio Workers Protest
Amneal Pharmaceuticals announced it will acquire biosimilar developer Alvotech for an upfront $375 million, with additional contingent payments tied to regulatory milestones. The deal expands Amneal’s pipeline into high‑margin biologics, adding several approved and late‑stage biosimilar candidates. Concurrently, workers at Samsung...
Improving Connecticut’s Public Health Through Cross-Sector Data-Sharing
Connecticut’s Prevention Data Portal, launched in 2018 by the State Epidemiological Outcomes Workgroup, aggregates local, state, and federal health data to support substance‑use prevention and broader public‑health initiatives. The portal’s success stems from an executive order mandating open data, strategic...
Why Quality Shareback Is the Missing Fuel for the Healthcare Interoperability Engine
Healthcare interoperability has largely solved data access, but the missing piece is high‑quality shareback—returning clinically relevant information after use. Patrick Lane argues that without structured, provenance‑rich, machine‑readable feedback, exchanges remain one‑way and fail to demonstrate outcome improvements. He outlines five...
Health Characteristics of Recreationally Active Female Cannabidiol Users: A Real-World Cross-Sectional Study
A cross‑sectional study of 149 recreationally active women aged 18‑40 examined real‑world cannabidiol (CBD) use. Current users (n=78) reported significantly lower physical activity, shorter sleep duration and poorer quality‑of‑life scores than non‑users, while dietary quality was modestly higher and tobacco...
Risk of Gastrointestinal Intolerance and Complications Associated with Homemade versus Commercial Enteral Nutrition in Critically Ill Patients: A Single-Center Retrospective...
A retrospective cohort of 605 ICU patients compared commercial enteral nutrition (CEN) with hospital‑compounded individualized commercial formulation (ICF). ICF patients experienced markedly lower diarrhea (13.6% vs 41.5%), fewer feeding interruptions, higher mean daily calories (951 kcal vs 893 kcal), and dramatically reduced...
An Evidence Mapping Study Based on Systematic Reviews of Traditional Chinese Medicine for Hyperuricemia
An umbrella review of eleven systematic reviews evaluated Traditional Chinese Medicine (TCM) and integrated TCM‑Western (ITCW) therapies for hyperuricemia. The pooled data suggest that both TCM monotherapy and ITCW reduce serum uric acid levels and improve total effective rates compared...
Adiponectin and Phase Angle in the Assessment of Sarcopenia in Crohn’s Disease: Beyond Muscle Mass
A recent Frontiers in Nutrition study evaluated 150 Crohn’s disease patients and found that both serum adiponectin levels and bioelectrical impedance‑derived phase angle are strong, independent predictors of sarcopenia. Only 8% of the cohort met full sarcopenia criteria, while 71%...
Rural Challenges May Dampen Digital Healthcare's Potential
The Rural Health Transformation Program (RHTP) will funnel $50 billion over five years to all 50 states, with each receiving between $147 million and $281 million in 2026. States must channel the money into digital‑health initiatives such as telehealth hubs, remote patient monitoring,...
Trump Administration Reclassifies Cannabis as Less Dangerous
The U.S. Department of Justice announced that products containing marijuana covered by the FDA or state medical licenses are being moved from Schedule I to Schedule III, putting them on par with codeine‑containing Tylenol. Acting Attorney General Todd Blanche made the change...
The Healthcare Industry Has a Last Mile Problem — It Hasn’t Realized It Yet
The article highlights a “last‑mile” gap in U.S. healthcare, where post‑appointment coordination for seniors often collapses. Discharges, medication adherence, and social‑determinant support lack dedicated resources, leading to readmissions and wasted care. Misaligned fee‑for‑service incentives and unclear accountability keep the problem...
DeepTek, Deepc to Partner on Integrated Radiology AI
DeepTek and deepc have combined their Augmento platform and deepcOS to create a fully integrated AI operating environment for radiology. The solution offers a single operational layer for deploying, orchestrating, and governing multi‑vendor AI across clinical workflows. It targets healthcare...
Planned Saskatchewan Law Will Raise Fines for Unauthorized Medical Practice
Bill 55, the Medical Profession Amendment Act 2026, will amend Saskatchewan’s Medical Profession Act and Regulated Health Professions Act to expand the College of Physicians and Surgeons of Saskatchewan’s investigative and enforcement powers. The legislation raises maximum fines for unauthorized practice...
Combative, Defensive and Occasionally Contrite, Kennedy Walks a Fine Line
Health Secretary Robert F. Kennedy Jr. endured a marathon of seven congressional hearings on President Trump’s budget, where he alternated between combative defenses and brief apologies. The hearings highlighted his fraught relationship with both the White House and his own base, especially over...
Ambience Healthcare Appoints Dr. Michael Han as CMO to Lead Clinical AI Strategy
Ambience Healthcare announced the appointment of Dr. Michael Han, MD, MBA, as its first Chief Medical Officer to lead the company’s clinical AI strategy and platform expansion. Han, formerly Enterprise CMIO at MultiCare Health System and a dual‑board‑certified urologist and...
Compounding Risk Alerts
The FDA continues to issue Compounding Risk Alerts to protect patients from unsafe, ineffective, or low‑quality compounded medicines. Recent alerts include potential safety risks from topical finasteride (April 22, 2025), dosing errors in injectable semaglutide (July 26, 2024), and adverse reactions linked to sulfite‑containing...
Kipu Health Acquires Team Recovery Technologies to Unify the Entire Behavioral Health Patient Journey
Kipu Health has acquired Team Recovery Technologies, adding mobile‑first alumni engagement tools to its already extensive behavioral‑health platform. The deal expands Kipu’s reach beyond clinical and billing functions to cover post‑discharge support, aiming to reduce relapse rates. Team Recovery serves...
Donald Trump Is Giving Psychedelic Medicines a Welcome Boost
President Donald Trump signed an executive order on April 18, 2026, after a text from podcaster Joe Rogan highlighted ibogaine’s potential for opioid addiction. The order directs the FDA to issue priority review vouchers for selected psychedelic drugs and earmarks new...
Mile Bluff Medical Center Says Security Incident that Involved Data Encryption Disrupted Phone, Computer Systems
Mile Bluff Medical Center in Mauston, Wisconsin, reported a security incident that encrypted data and disrupted phone and computer systems. Clinical teams immediately shifted to downtime procedures to keep patient care flowing while the hospital activated its security protocols. An...
Endpoints Wins Neal Awards for Trump and Gene Editing Coverage, JPM Event
Endpoints News earned three 2026 Neal Awards, honoring its in‑depth reporting on the pharmaceutical sector’s ties to the Trump administration, a three‑part series on gene‑editing breakthroughs, and its coverage of the JPMorgan health‑care conference. The awards, presented by the American...
New Primary Care Firm Mangrove Health Launches with Investment by Mako
Mangrove Health, a new primary‑care operator, was launched by seasoned healthcare leaders Elena Castañeda and Dr. Emily Maxson. The startup secured an investment from venture firm Mako, signaling confidence in its model. Mangrove aims to deliver integrated, technology‑enabled primary‑care services...
Insured Americans Face Significant Hurdles to Mental Health Services
The Mental Health Parity Index reveals that the nation’s four largest commercial insurers provide significantly fewer in‑network mental‑health and substance‑use disorder providers than physical‑health clinicians, with gaps ranging from 24% to 83%. Clinician reimbursement for behavioral health services is 16%‑59%...
HHS, Industry Leaders Spar over Drug Pricing, TrumpRx and PBMs
At a Politico‑hosted summit, U.S. health officials and pharma leaders clashed over the most‑favored‑nation (MFN) drug‑pricing policy championed by the Trump administration. The MFN proposal would force manufacturers to price drugs in the United States at levels comparable to lower‑cost...
Unnamed Pharma Files Citizen Petition Targeting FDA’s Trove of Rejection Letters
An unnamed pharmaceutical firm has lodged a citizen petition urging the FDA to halt its new practice of automatically publishing complete response letters (CRLs). The petition seeks a 10‑day notice period for sponsors to contest disclosure and a clear redaction...
These 80-Year-Olds Have the Memory of 50-Year-Olds. Scientists Now Know Why
Northwestern Medicine’s 25‑year SuperAging program has identified a cohort of 80‑plus adults whose memory performance matches that of people in their 50s. Researchers found that these “SuperAgers” exhibit unusually thick cortical regions and a higher density of von Economo neurons, which...
AAN 2026: J&J, Kyverna, Capricor and Praxis Showcase Practice-Changing Data
At the 2026 American Academy of Neurology meeting, Johnson & Johnson reported two‑year Phase 3 data showing its FcRn blocker Imaavy sustained symptom improvement and allowed most patients to cut corticosteroid use. Kyverna Therapeutics presented Phase 2 results for its CAR‑T therapy...
DemeRx Reports the US FDA IND Application Acceptance to Advance DMX-1001 for Alcohol Use Disorder
DemeRx announced that the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND) application for DMX-1001, an oral formulation of noribogaine, to treat alcohol use disorder (AUD). The company recently completed a multiple‑ascending‑dose (MAD) trial in healthy...
Senior Lucy Letby Hospital Boss Arrested
A senior executive at the Countess of Chester Hospital was arrested on suspicion of perverting the course of justice, part of Cheshire Police's Operation Duet. The operation investigates both corporate manslaughter and gross negligence manslaughter linked to the 2023 convictions of...
UNPACKING THE CHALLENGES FACING SOUTH AFRICA’S HEALTHCARE REFORM
South Africa’s post‑apartheid health system has shifted toward greater inclusivity, but stark gaps between public and private care persist. The National Health Insurance scheme, touted as a path to universal coverage, faces a Constitutional Court decision slated for May 2026, prompting...
Gravity Rail Raises $2.75M From Redesign Health for AI Patient Communication
Gravity Rail, an AI‑driven platform that automates patient calls, texts and follow‑up workflows, announced a $2.75 million seed round led by Redesign Health. The funding will accelerate product development and expand its go‑to‑market team. Gravity Rail’s technology aims to streamline enrollment,...
Infinitus Systems Launches “Studio”: The First No-Code AI Agent Builder Purpose-Built for Healthcare Complexity
Infinitus Systems has launched Studio, a no‑code AI agent builder designed specifically for healthcare. The platform lets operational teams create and deploy agents via a natural‑language interface, cutting deployment time by 90% and boosting accuracy 40% over manual methods. Its...
UFP Technologies: Great Growth At Just An Okay Price
UFP Technologies (UFPT) is delivering strong revenue and profit growth in the MedTech space, fueled by strategic acquisitions and expanding exposure to high‑growth areas such as robotic surgery and infection‑prevention products. The company benefits from a $550 billion MedTech market and...
Algeria Eliminates Trachoma as a Public Health Problem
The World Health Organization has officially validated Algeria’s elimination of trachoma as a public health problem, making it the 10th country in the African Region and the 29th worldwide to achieve this status. Trachoma, the leading infectious cause of blindness,...
Regeneron and Sanofi Report the US FDA Approval of Dupixent (Dupilumab) for Chronic Spontaneous Urticaria (CSU)
Regeneron and Sanofi announced that the U.S. Food and Drug Administration has approved Dupixent (dupilumab) for chronic spontaneous urticaria (CSU) in patients as young as two years old who remain symptomatic despite H1 antihistamines. The decision is based on two...
Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins
Dexcom (DXCM) is positioned to profit from the booming weight‑loss drug market, as GLP‑1 therapies drive both new diabetes diagnoses and higher CGM adoption among patients. The company reports faster CGM usage growth among GLP‑1 users and highlights a still‑under‑penetrated...
How Employers End up Paying for Weight Gain
Employers are rapidly adding GLP‑1 weight‑loss drugs to health plans, but more than half of participants abandon therapy within a year, eroding the expected return on investment. While some firms pair prescriptions with nutrition coaching and behavior‑change programs, only about...
Oura’s Strategic Acquisition of Galen AI and the Future of Personal Medical Sovereignty
On April 17, 2026 Oura Health announced the acquisition of Galen AI, a Stanford‑born startup that unifies fragmented medical records via FHIR. The deal expands Oura’s smart ring from a fitness tracker to a connected health companion that can cross‑reference...
/file/attachments/orphans/Image-1-Bukhosi-Mdletshe_405154.jpg)
SPOTLIGHT: ‘I’m Serving My People’: The Pastor Running a Rural Clinic that Treats More than Illness
Bukhosi Mdletshe, a pastor and operational manager of Ensingweni Clinic in KwaZulu‑Natal’s King Cetshwayo District, oversees a rural health hub serving roughly 12,000 people spread across a 60‑km area. The clinic combines basic medical services with proactive home‑based care, deploying...
Novo Nordisk’s Oral Semaglutide Demonstrates Potential to Be the First Oral GLP-1 RA Therapy for Children and Adolescents with Type...
Novo Nordisk reported positive topline results from the phase 3a PIONEER TEENS trial, the first study of an oral GLP‑1 receptor agonist in children and adolescents with type 2 diabetes. Oral semaglutide lowered HbA1c by 0.83 percentage points versus placebo...
Are You Waiting for Opioid Settlement Money From Purdue, Mallinckrodt or Endo? Get in Touch.
ProPublica and The Philadelphia Inquirer are probing how victims of the U.S. opioid crisis are being compensated under the bankruptcy settlements of Purdue Pharma, Mallinckrodt and Endo. A recent investigation highlights that Purdue’s revised bankruptcy plan trims payouts and omits...
Operational Lessons From Global Nephrology Trials
The article outlines four operational lessons drawn from the surge of global nephrology trials, noting that GlobalData tracks 888 CKD studies with only 56 multinational efforts. It argues that traditional site selection in Europe and the U.S. limits enrollment speed...
Could Anemia Increase the Risk of Developing Dementia?
A Swedish cohort of 2,282 adults aged 60+ was followed for up to 16 years to examine anemia’s link to dementia. Researchers found that baseline anemia raised the risk of developing dementia by 66 % compared with normal hemoglobin levels. The...
WHO Reports Measurable Health Impact in 2025 Amid Transition to New Strategy
The World Health Organization released its 2025 Results Report, the final assessment of its Thirteenth General Programme of Work, showing measurable progress across the Triple Billion targets despite funding cuts. Compared with a 2018 baseline, an extra 567 million people accessed...
FDA Grants Clearance for Philips’ Rembra Scanning Platform
Philips has secured FDA 510(k) clearance for its Rembra platform, encompassing the Rembra CT scanner, Rembra RT and Areta RT radiation‑therapy systems. The CT unit features an 85 cm bore and can handle up to 270 exams per day, targeting high‑throughput...
ModeX Starts Dosing in MDX2003 Trial for B-Cell Lymphoma
ModeX Therapeutics, an OPKO Health subsidiary, has begun dosing the first patients in the MDX‑2003‑101 trial of its tetraspecific T‑cell engager MDX2003 for relapsed or refractory B‑cell lymphoma. The study will evaluate tolerability, pharmacokinetics, safety and immune activity across dose‑escalation...
Epitopea Wins UK Approval for Therapeutic Vaccine Trial
Epitopea secured UK regulator and ethics committee clearance to launch OVACT, a Phase I/Ib first‑in‑human trial of its RNA‑based vaccine CryptiVax‑1001 in advanced high‑grade serous ovarian cancer. The study will evaluate safety, tolerability, immunogenicity and early clinical activity in HRP⁺/BRCA‑wildtype...
New Case Law Could Put Radiologists on Hook for Imaging-Order Appropriateness
A 2025 Ohio appellate decision, Kelley v. Horton, allowed the American College of Radiology’s Appropriateness Criteria to be used in a malpractice trial, marking the first time the guidelines were admitted as evidence. The case involved two MRIs ordered by...